Animal Intestinal Health Market Size, Share and Growth Outlook, 2026

Animal Intestinal Health Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Animal Intestinal Health Market size is forecast to increase from $5.51 Billion in 2026 to $10.27 Billion in 2034 at a CAGR of 8.1% between 2026 and 2034.

The Animal Intestinal Health market report provides detailed analysis and outlook of Animal Intestinal Health segments including By Additive Type (Probiotics, Prebiotics, Phytogenics, Immunostimulants, Postbiotics, Enzymes), By Animal Type (Poultry, Swine, Ruminants, Aquaculture, Companion Animals ), By Form (Dry, Liquid), By Source (Microbial, Plant-Based), By Application (Performance & Growth Promotion, Disease Prevention, Nutrient Digestion & Metabolism, Immunity Enhancement) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Animal Intestinal Health Industry Overview

Scientific Standardization Strengthening Probiotic Development

The animal intestinal health industry is advancing rapidly as scientific research, microbiome innovation, and precision nutrition strategies become central to livestock and companion animal health management. A major milestone in the sector has been the release of the Scientific Consensus on Next-Generation Probiotics and the Scientific Consensus on Precise Identification of Probiotic Strains by the Probiotics Branch of the Chinese Institute of Food Science and Technology. These consensus documents establish standardized frameworks for evaluating probiotic efficacy, safety, and strain-level identification. The introduction of standardized technical pathways is expected to improve product consistency, strengthen scientific validation, and support the development of more effective gut health solutions for animal nutrition applications. Such initiatives are helping create a stronger regulatory and scientific foundation for the expanding probiotics market.

Advanced Probiotic Formulations Enhancing Gut Microbiota Management

Innovation in probiotic technologies continues to drive growth within the animal intestinal health sector. A notable development involves the authorization of a patent for a compound probiotic preparation developed by Angel Yeast and Angel Nutritech. The formulation is specifically designed to regulate intestinal microbiota and reduce the production of harmful intestinal gases. The patented product combines three targeted microbial strains: Bifidobacterium animalis subsp. lactis Bi66, Lactiplantibacillus plantarum P16, and Saccharomyces boulardii Bld-3. The development highlights increasing industry interest in multi-strain probiotic solutions capable of delivering enhanced digestive health benefits and supporting balanced gut microbial ecosystems across livestock and companion animal populations.

Microbiome Engineering Creating Precision Nutrition Opportunities

The industry is increasingly shifting toward next-generation microbiome engineering approaches that move beyond traditional probiotic supplementation. Precision-formulated microbial proteins and targeted prebiotics are being developed to selectively influence beneficial microbial populations within species-specific gastrointestinal environments. Rather than applying generic gut health solutions across animal categories, manufacturers are focusing on customized formulations designed for poultry, swine, aquaculture, and other production systems based on their unique microbiome characteristics. This precision-based approach aims to optimize nutrient utilization, improve intestinal integrity, enhance immune function, and support overall animal performance. The growing integration of microbiome science, microbial engineering, and precision nutrition is reshaping the animal intestinal health industry and driving the development of highly specialized gut health products for modern animal production systems.

Animal Intestinal Health Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Animal Intestinal Health market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Cargill, Incorporated, Alltech, Inc., Kemin Industries, Inc., Koninklijke DSM N.V., Chr. Hansen Holding A/S, Novozymes A/S, Evonik Industries AG, Archer-Daniels-Midland Company (ADM), Adisseo (Bluestar Adisseo), Land O'Lakes, Inc.. The Animal Intestinal Health market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Animal Intestinal Health industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Animal Intestinal Health Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Animal Intestinal Health companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Animal Intestinal Health markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Animal Intestinal Health Market Competitive Benchmarking and Company Analysis

Leading companies in Animal Intestinal Health industry include- Cargill, Incorporated, Alltech, Inc., Kemin Industries, Inc., Koninklijke DSM N.V., Chr. Hansen Holding A/S, Novozymes A/S, Evonik Industries AG, Archer-Daniels-Midland Company (ADM), Adisseo (Bluestar Adisseo), Land O'Lakes, Inc.. The Animal Intestinal Health market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Animal Intestinal Health Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Animal Intestinal Health market remains one of the strongest-performing segments in the country.
The US Animal Intestinal Health Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Animal Intestinal Health market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Animal Intestinal Health industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Animal Intestinal Health markets

Canada's strong Animal Intestinal Health sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Animal Intestinal Health market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Animal Intestinal Health Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Animal Intestinal Health market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Animal Intestinal Health population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Animal Intestinal Health industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Animal Intestinal Health market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Animal Intestinal Health sales through 2034

France Animal Intestinal Health companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Animal Intestinal Health Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Animal Intestinal Health distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Animal Intestinal Health Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Animal Intestinal Health market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Animal Intestinal Health industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Animal Intestinal Health industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Animal Intestinal Health Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Animal Intestinal Health market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Animal Intestinal Health market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Animal Intestinal Health Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Animal Intestinal Health Market Segmentation

By Additive Type
Probiotics
Prebiotics
Phytogenics
Immunostimulants
Postbiotics
Enzymes
By Animal Type
Poultry
Swine
Ruminants
Aquaculture
Companion Animals
By Form
Dry
Liquid
By Source
Microbial
Plant-Based
By Application
Performance & Growth Promotion
Disease Prevention
Nutrient Digestion & Metabolism
Immunity Enhancement

Top Companies in Animal Intestinal Health Industry

Cargill, Incorporated
Alltech, Inc.
Kemin Industries, Inc.
Koninklijke DSM N.V.
Chr. Hansen Holding A/S
Novozymes A/S
Evonik Industries AG
Archer-Daniels-Midland Company (ADM)
Adisseo (Bluestar Adisseo)
Land O'Lakes, Inc.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa